Re: OTC Expert & Grey Market Restrictions
in response to
by
posted on
Nov 23, 2022 05:00PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
golf... yes it's a complete shot in the dark as to what is available in shares and Bid/Ask.
Glad to see that the stock is still liquid on the OTC.
Koo